Lexoziff PD Eye Drops contain Levofloxacin 1.5% w/v + Prednisolone Acetate 1% w/v, a dual-action ophthalmic formulation designed to treat bacterial eye infections with inflammation. Its combination ensures rapid infection control and effective reduction of ocular inflammation.
Levofloxacin acts as a broad-spectrum fluoroquinolone antibiotic, eliminating bacterial pathogens, while Prednisolone provides potent steroidal anti-inflammatory action, reducing redness, swelling, and ocular discomfort.
From a commercial perspective, Lexoziff PD Eye Drops are a high-demand steroid-antibiotic ophthalmic product, widely prescribed in eye hospitals, clinics, and post-operative care centers, ensuring consistent demand and repeat prescriptions.
Adding Lexoziff PD Eye Drops to your portfolio strengthens the ophthalmic steroid-antibiotic segment, offering long-term business growth, strong prescriber trust, and enhanced portfolio credibility for PCD pharma franchise partners.